# IORT on Borderline Resectable Pancreatic Cancer

> **NCT04090463** · PHASE2 · SUSPENDED · sponsor: **Universita di Verona** · enrollment: 100 (estimated)

## Conditions studied

- Borderline Resectable Pancreatic Cancer

## Interventions

- **RADIATION:** Intraoperative radiotherapy

## Key facts

- **NCT ID:** NCT04090463
- **Lead sponsor:** Universita di Verona
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2019-10-01
- **Primary completion:** 2027-10-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 100 (ESTIMATED)
- **Why stopped:** Logistic and financial reasons
- **Last updated:** 2024-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04090463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04090463, "IORT on Borderline Resectable Pancreatic Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04090463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*